Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012572
Filing Date
2019-08-14
Accepted
2019-08-14 16:31:42
Documents
68
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 746507
2 ex10-1.htm EX-10.1 153153
3 ex10-2.htm EX-10.2 60543
4 ex10-3.htm EX-10.3 78403
5 ex31-1.htm EX-31.1 19728
6 ex31-2.htm EX-31.2 19532
7 ex32-1.htm EX-32.1 7458
8 ex32-2.htm EX-32.2 7423
  Complete submission text file 0001493152-19-012572.txt   5032434

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE heb-20190630.xml EX-101.INS 913035
10 XBRL SCHEMA FILE heb-20190630.xsd EX-101.SCH 67317
11 XBRL CALCULATION FILE heb-20190630_cal.xml EX-101.CAL 62955
12 XBRL DEFINITION FILE heb-20190630_def.xml EX-101.DEF 219967
13 XBRL LABEL FILE heb-20190630_lab.xml EX-101.LAB 423437
14 XBRL PRESENTATION FILE heb-20190630_pre.xml EX-101.PRE 280863
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 191026943
SIC: 2836 Biological Products, (No Diagnostic Substances)